×
About 7,825 results

ALLMedicine™ Hyponatremia Center

Research & Reviews  2,212 results

Serum sodium, cognition and incident dementia in the general population.
https://doi.org/10.1093/ageing/afad007
Age and Ageing; van der Burgh AC, Pelouto A et. al.

Feb 4th, 2023 - Low serum sodium may be associated with cognitive impairment and dementia in the general population, but the data remain inconclusive. Therefore, we aimed to determine the association of low serum sodium with cognitive function and incident dement...

Fluid restriction reduces delayed hyponatremia and hospital readmissions after transsph...
https://doi.org/10.1210/clinem/dgad066
The Journal of Clinical Endocrinology and Metabolism; Cooper O, Lis R et. al.

Feb 2nd, 2023 - Postoperative hyponatremia leads to prolonged hospital length of stay and readmission within 30 days. To assess 3 strategies for reducing rates of postoperative hyponatremia and analyze risk factors for hyponatremia. 2 retrospective analyses and 1...

Hypo-osmolarity induces apoptosis resistance via TRPV2-mediated AKT-Bcl-2 pathway.
https://doi.org/10.1152/ajpgi.00138.2022
American Journal of Physiology. Gastrointestinal and Live... Urushima H, Matsubara T et. al.

Feb 1st, 2023 - In cirrhosis, several molecular alterations such as resistance to apoptosis could accelerate carcinogenesis. Recently, mechanotransduction has been attracting attention as one of the causes of these disturbances. In cirrhosis patients, the serum s...

Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome
https://clinicaltrials.gov/ct2/show/NCT05055856

Jan 31st, 2023 - The demographic evolution represents a challenge for the general public health. The global population, especially in the developed countries, is aging. Aging is associated with a decrease of physio-logical functions leading to frailty. Frailty is ...

Aquaporins in Edema.
https://doi.org/10.1007/978-981-19-7415-1_19
Advances in Experimental Medicine and Biology; Li N, Ying Y et. al.

Jan 31st, 2023 - One of the most prevalent indications of water-electrolyte imbalance is edema. Aquaporins (AQPs) are a protein family that can function as water channels. Osmoregulation and body water homeostasis are dependent on the regulation of AQPs. Human kid...

see more →

Guidelines  8 results

AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: E...
https://doi.org/10.1053/j.gastro.2022.11.034
Gastroenterology Wang B, Bonkovsky HL et. al.

Jan 16th, 2023 - The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase. Ac...

Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-...
https://doi.org/10.1016/j.wem.2019.11.003
Wilderness & Environmental Medicine; Bennett BL, Hew-Butler T et. al.

Feb 12th, 2020 - Exercise-associated hyponatremia (EAH) is defined by a serum or plasma sodium concentration below the normal reference range of 135 mmol·L-1 that occurs during or up to 24 h after prolonged physical activity. It is reported to occur in individual ...

International Continence Society consensus on the diagnosis and treatment of nocturia.
https://doi.org/10.1002/nau.23939
Neurourology and Urodynamics; Everaert K, Hervé F et. al.

Feb 20th, 2019 - Patients with nocturia have to face many hurdles before being diagnosed and treated properly. The aim of this paper is to: summarize the nocturia patient pathway, explore how nocturia is diagnosed and treated in the real world and use the Delphi m...

Choosing Wisely in pediatric anesthesia: An interpretation from the German Scientific W...
https://doi.org/10.1111/pan.13383
Paediatric Anaesthesia; Becke K, Eich C et. al.

Jun 1st, 2018 - Inspired by the Choosing Wisely initiative, a group of pediatric anesthesiologists representing the German Working Group on Paediatric Anaesthesia (WAKKA) coined and agreed upon 10 concise positive ("dos") or negative ("don'ts") evidence-based rec...

Approach to hyponatremia according to the clinical setting: Consensus statement from th...
https://doi.org/10.1007/s40618-017-0776-x
Journal of Endocrinological Investigation; Sbardella E, Isidori AM et. al.

Nov 21st, 2017 - Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).|2017|Sbardella E,Isidori AM,A...

see more →

Drugs  257 results see all →

Clinicaltrials.gov  187 results

Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome
https://clinicaltrials.gov/ct2/show/NCT05055856

Jan 31st, 2023 - The demographic evolution represents a challenge for the general public health. The global population, especially in the developed countries, is aging. Aging is associated with a decrease of physio-logical functions leading to frailty. Frailty is ...

History of the KSHV Inflammatory Cytokine Syndrome (KICS)
https://clinicaltrials.gov/ct2/show/NCT01419561

Jan 23rd, 2023 - BACKGROUND: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV). It is characterized by severe inflammatory symptoms including fevers, wasting, cytopenias, hypoalbuminemi...

Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial
https://clinicaltrials.gov/ct2/show/NCT05692726

Jan 23rd, 2023 - Achieving recommended treatment targets in management of hyponatremia is challenging: plasma sodium must be increased effectively but, at the same time, overcorrection has to be prevented. Yet, predictors of change of sodium over time have not bee...

Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
https://clinicaltrials.gov/ct2/show/NCT04329975

Jan 11th, 2023 - To investigate the incidence and risk factors of desmopressin-induced hyponatremia during long-term treatment (1 year [52 weeks]) of MINIRINMELT orally disintegrating (OD) tablets 25μg/50μg (drug) for nocturia caused by nocturnal polyuria in men i...

The Treatment of Adrenal Crisis With Inhaled Prednisolone
https://clinicaltrials.gov/ct2/show/NCT05639127

Dec 6th, 2022 - The prevalence of adrenal insufficiency is approximately 30-50 individuals per 100.0001. Patients with adrenal insufficiency rely on glucocorticoid substitution therapy (hydrocortisone or cortisone acetate). In case of an acute stressful situation...

see more →

News  459 results

FDA Greenlights First Drug for ESR1-Mutated Breast Cancer
https://www.medpagetoday.com/hematologyoncology/breastcancer/102880

Jan 30th, 2023 - The FDA approved the selective estrogen receptor (ER) degrader elacestrant (Orserdu) for the treatment of postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression...

Medication-induced rhabdomyolysis in a patient with bipolar disorder
https://www.mdedge.com/psychiatry/article/260760/bipolar-disorder/medication-induced-rhabdomyolysis-patient-bipolar
Jayasudha Gude, MD, Viwek Bisen, DO et. al.

Jan 24th, 2023 - Editor’s note: Readers’ Forum is a department for correspondence from readers that is not in response to articles published in Current Psychiatry. All submissions to Readers’ Forum undergo peer review and are subject to editing for length and styl.

Electrolyte Disturbances a Harbinger of Eating Disorders?
https://www.medscape.com/viewarticle/984087

Nov 15th, 2022 - Electrolyte abnormalities may serve as a precursor to a future eating disorder diagnosis, a finding that may help pinpoint candidates for screening. Researchers found that adolescents and adults with electrolyte abnormalities on routine outpatient...

FDA Approves Tremelimumab Plus Durvalumab and Chemo for Metastatic NSCLC
https://www.onclive.com/view/fda-approves-tremelimumab-plus-durvalumab-and-chemo-for-metastatic-nsclc

Nov 10th, 2022 - The FDA has approved tremelimumab-actl (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non–small cell lung cancer (NSCLC) without sensitizing EGFR mutation or ALK aberrations.1-3 The regulator...

Pembrolizumab Plus Cabozantinib Improves ORR in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
https://www.onclive.com/view/pembrolizumab-plus-cabozantinib-improves-orr-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma

Nov 8th, 2022 - A doublet regimen comprised of pembrolizumab (Keytruda) and cabozantinib (Cabometyx) elicited encouraging responses in patients with recurrent metastatic head and neck squamous cell carcinoma (HNSCC), meeting the primary end point of a phase 2 tri...

see more →

Patient Education  7 results see all →